Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability

BACKGROUND: Hepatitis C virus infection and interferon treatment are often associated with anxiety, depressive symptoms and poor health-related quality of life. To evaluate the Silybin-vitamin E-phospholipids complex effect on work ability and whether health related factors (anxiety and depression)...

Descripción completa

Detalles Bibliográficos
Autores principales: Malaguarnera, Giulia, Bertino, Gaetano, Chisari, Giuseppe, Motta, Massimo, Vecchio, Michele, Vacante, Marco, Caraci, Filippo, Greco, Carmela, Drago, Filippo, Nunnari, Giuseppe, Malaguarnera, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109776/
https://www.ncbi.nlm.nih.gov/pubmed/27842532
http://dx.doi.org/10.1186/s12888-016-1115-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109776/
https://www.ncbi.nlm.nih.gov/pubmed/27842532
http://dx.doi.org/10.1186/s12888-016-1115-z

Ejemplares similares